Lifeaz raises €13M to further its efforts to improve access to life-saving interventions

2026-02-12 · Source: Tech.eu - Tech.eu · Field: Health & Wellbeing — Medical Devices & Health Technology, Clinical Care & Medical Practice, Public Health & Epidemiology · Depth: Fundamental Awareness, quick

Summary

Lifeaz, a France-based company, has secured €13 million in a funding round to advance its mission of improving access to defibrillators for individuals and businesses. The investment saw continued participation from Mutuelles Impact, managed by XAnge, and new contributions from BNP Paribas, GO CAPITAL, and Mirova. Founded in 2015, Lifeaz develops user-friendly, connected defibrillators that offer step-by-step visual and audio guidance, even for untrained users. These devices feature remote monitoring and automated self-checks to ensure operational readiness. Beyond hardware, Lifeaz provides training via a free mobile app and in-person workshops. The company plans to expand its customer base, increase lives saved, initiate a broader European rollout, and grow its team.

Key takeaway

For business owners and facility managers evaluating emergency preparedness solutions, Lifeaz's €13 million funding and integrated approach suggest a robust, expanding option. You should consider their connected defibrillators and training programs to enhance safety and ensure staff readiness for life-saving interventions, particularly as they scale across Europe.

Key insights

Integrated hardware, software, and training improve defibrillator accessibility and emergency preparedness.

Principles

• Simplicity enhances emergency device usability.
• Connectivity ensures device readiness and monitoring.

Method

Lifeaz combines easy-to-use, connected defibrillators with remote monitoring and comprehensive training via a mobile app and workshops to boost emergency response capabilities.

In practice

• Deploy connected AEDs for remote oversight.
• Offer guided training for emergency equipment.

Topics

• Defibrillators
• Emergency Preparedness
• Medical Devices
• Funding Round
• European Expansion

Best for: Investor, Entrepreneur, Business Analyst

Related on AIssential

• French health insurance outfit Alan agrees €480M funding round — Alan's significant funding round validates an integrated, AI-powered approach to proactive health and prevention insurance.
• Efferon secures €2.5M to grow blood purification platform — Efferon's hemoadsorption devices provide a certified solution for sepsis and septic shock, including a first-in-Europe pediatric version.
• Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million — Bridging US biopharma expertise with Europe's ecosystem creates significant life sciences investment opportunities.
• Can AI Help Save Lives? — AI significantly enhances public safety by automating routine tasks and augmenting emergency response capabilities.
• Exclusive: British Business Bank to back UK scaleups with £400m per year — The British Business Bank is deploying significant capital to bridge the UK's scaleup funding gap, particularly for larger growth rounds.
• Ebola outbreak requires multifaceted response — Global challenges demand integrated, proactive responses, while rapid AI advancement necessitates urgent safety and infrastructure considerations.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Tech.eu - Tech.eu.